As patients with obesity are at increased cardiovascular risk [51] and are more likely to receive a GLP-1-RA than a DPP-4i, the bias introduced by underreporting obesity would be conservative, favoring the null hypothesis. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.